FIORAVANTI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 3.151
EU - Europa 1.021
AS - Asia 410
AF - Africa 40
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.635
Nazione #
US - Stati Uniti d'America 3.100
IT - Italia 293
DE - Germania 238
CN - Cina 171
SE - Svezia 166
SG - Singapore 101
BG - Bulgaria 87
GB - Regno Unito 74
TR - Turchia 55
VN - Vietnam 53
CA - Canada 49
AT - Austria 44
FI - Finlandia 33
CI - Costa d'Avorio 25
FR - Francia 23
UA - Ucraina 21
BE - Belgio 18
IN - India 18
NG - Nigeria 8
RU - Federazione Russa 7
HK - Hong Kong 6
NL - Olanda 6
SN - Senegal 6
AU - Australia 4
BR - Brasile 4
DK - Danimarca 4
CH - Svizzera 3
CZ - Repubblica Ceca 2
JP - Giappone 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IE - Irlanda 1
MX - Messico 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 4.635
Città #
Woodbridge 425
Ann Arbor 408
Fairfield 384
Houston 318
Chandler 222
Seattle 182
Ashburn 179
Wilmington 170
Cambridge 138
Serra 132
Sofia 87
Singapore 67
Beijing 58
New York 56
Ottawa 47
Boardman 45
Vienna 43
Dong Ket 39
Santa Clara 37
Des Moines 36
Izmir 36
Princeton 36
Medford 35
Lawrence 34
Dearborn 26
Falls Church 26
Abidjan 25
Rho 19
Boulder 18
Brussels 18
Nanjing 18
Jacksonville 17
Istanbul 16
San Diego 16
Florence 15
Nürnberg 15
London 14
Bremen 12
Fuzhou 12
Nanchang 11
Pune 11
Seacroft 11
Frankfurt am Main 10
Milan 10
Düsseldorf 9
Shenyang 9
Lagos 8
Los Angeles 8
Ogden 8
Redwood City 8
Marseille 7
Pisa 7
Shanghai 7
Dakar 6
Hong Kong 6
Lancaster 6
Dallas 5
Norwalk 5
Changsha 4
Indiana 4
Kunming 4
San Francisco 4
Auburn Hills 3
Copenhagen 3
Hefei 3
Jiaxing 3
Phoenix 3
Quanzhou 3
São Paulo 3
Tianjin 3
Amsterdam 2
Chengdu 2
Groningen 2
Hangzhou 2
Hebei 2
Jüchen 2
Kocaeli 2
La Canada Flintridge 2
Massa 2
Melbourne 2
Positano 2
Simi Valley 2
Tappahannock 2
Washington 2
Wuhan 2
Alexandria 1
Atlanta 1
Bandar Seri Begawan 1
Bern 1
Brno 1
Buffalo 1
Canberra 1
Casoria 1
Cecina 1
Cotonou 1
Council Bluffs 1
Delhi 1
Dublin 1
Edinburgh 1
Foshan 1
Totale 3.718
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 320
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 197
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 192
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 189
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 175
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 167
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 164
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 159
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 151
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 146
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 145
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 144
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 144
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 143
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 141
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 126
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 119
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 117
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer 116
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis. 116
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: evaluation of the effects of switched schedules and related pharmacodynamics 114
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 112
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells 108
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer 107
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells 106
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells 104
Derivati a nucleo pirazolo[3,4-d]pirimidinico quali inibitori di proteine tirosina chinasi 104
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer 101
null 101
Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions 100
null 89
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients 87
Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity. 86
A new biometric tool for three-dimensional subcutaneous tumor scanning in mice. 81
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1 81
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients 42
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. 36
Totale 4.730
Categoria #
all - tutte 12.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020696 0 0 0 0 105 119 117 92 110 65 69 19
2020/2021460 57 54 46 19 30 22 7 48 36 51 26 64
2021/2022473 10 41 20 14 76 65 16 21 25 26 22 137
2022/2023652 85 99 60 74 66 89 3 37 105 2 29 3
2023/2024244 21 18 27 5 26 64 9 20 5 6 14 29
2024/2025200 3 44 5 90 58 0 0 0 0 0 0 0
Totale 4.730